AKT1 and acute myeloid leukemia: Further studies have revealed that the Pim kinases partially protect the mTORC1 pathway when the PI3K/Akt pathway is inhibited to mitigate downregulation of Mcl-1 expression to maintain survival of FLT3-ITD-expressing cells, including primary AML cells.